Amneal Pharmaceuticals AMRX reported its Q2 earnings results on Friday, August 5, 2022 at 06:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Amneal Pharmaceuticals missed estimated earnings by 5.0%, reporting an EPS of $0.19 versus an estimate of $0.2.
Revenue was up $24.28 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 4.83% drop in the share price the next day.
Here’s a look at Amneal Pharmaceuticals’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.13 | 0.20 | 0.20 | 0.19 |
| EPS Actual | 0.12 | 0.18 | 0.21 | 0.25 |
| Revenue Estimate | 503.97M | 537.35M | 545.06M | 523.25M |
| Revenue Actual | 497.63M | 536.90M | 528.59M | 535.08M |
To track all earnings releases for Amneal Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Image and article originally from www.benzinga.com. Read the original article here.